| | Characteristics | Non-CR (N = 12) | CR (N = 12) | value |
| | Age, years# | 59.75 ± 12.63 | 67.50 ± 12.82 | 0.150 | | Height (m)# | 1.68 ± 0.08 | 1.64 ± 0.08 | 0.227 | | Weight (Kg)# | 67.50 ± 9.26 | 64.50 ± 10.49 | 0.466 | | BMI (Kg/m2)# | 23.97 ± 3.11 | 23.84 ± 2.31 | 0.911 | | Oxygen saturation (%) | 90.5 (89.0, 92.8) | 90.0 (90.0, 92.0) | 0.630 | | SBP (mmHg)# | 119.1 ± 24.6 | 125.2 ± 34.4 | 0.623 | | DBP (mmHg)# | 74.8 ± 17.3 | 73.4 ± 17.1 | 0.851 | | Heart rate# | 73.8 ± 16.4 | 70.3 ± 16.5 | 0.607 | | White blood cell | 7.35 (5.36, 9.55) | 9.08 (6.86, 15.20) | 0.266 | | Red blood cell | 4.55 (3.78, 5.49) | 4.79 (4.19, 5.19) | 0.731 | | Hemoglobin# | 141.1 ± 38.3 | 149.0 ± 20.1 | 0.533 | | Glycosylated hemoglobin | 5.69 (5.26, 7.04) | 6.01 (5.81, 6.91) | 0.291 | | PT | 12.1 (11.9, 13.3) | 12.3 (11.9, 13.5) | 0.799 | | APTT | 31.8 (27.2, 35.0) | 29.4 (23.6, 32.0) | 0.114 | | ALT | 45.0 (12.0, 134.8) | 35.5 (20.3, 51.8) | 0.887 | | AST | 43.0 (20.0, 771.8) | 44.5 (23.3, 106.0) | 0.843 | | AST/ALT | 1.0 (0.7, 4.7) | 1.1 (0.6, 2.1) | 0.887 | | Urea nitrogen | 8.56 (5.99, 13.66) | 7.16 (5.13, 8.80) | 0.443 | | Creatinine | 93.5 (76.3, 127.5) | 82.5 (72.8, 88.5) | 0.319 | | Glomerular filtration rate (mL/min × 1.73 m2)# | 65.5 ± 22.6 | 76.4 ± 27.3 | 0.297 | | Albumin | 37.7 (32.6, 41.0) | 36.2 (33.2, 38.3) | 0.833 | | Total cholesterol (mmol/L)# | 3.84 ± 1.62 | 4.20 ± 1.10 | 0.528 | | Triglyceride | 1.38 (0.92, 1.95) | 1.16 (0.89, 2.09) | 0.799 | | TSH | 1.12 (0.36, 2.94) | 2.04 (1.26, 2.90) | 0.211 |
| | Sex, n (%) | | | 1.000 | | Male | 9 (75.0) | 9 (75.0) | | | Female | 3 (25.0) | 3 (25.0) | |
| | Aspirin resistance, n (%) | | | 0.102 | | No | 8 (66.7) | 4 (33.3) | | | Yes | 4 (33.3) | 8 (66.7) | |
| | Smoking history, n (%) | | | 0.342 | | No | 10 (83.3) | 8 (66.7) | | | Yes | 2 (16.7) | 4 (33.3) | |
| | Coronary heart disease type, n (%) | | | 0.618 | | STEMI | 5 (41.7) | 6 (50.0) | | | NSTEMI | 3 (25.0) | 1 (8.3) | | | SAP | 0 (0.0) | 4 (33.3) | | | UA | 4 (33.3) | 1 (8.3) | |
| | Hypertension, n (%) | | | 1.000 | | No | 5 (41.7) | 5 (41.7) | | | Yes | 7 (58.3) | 7 (58.3) | |
| | Diabetes, n (%) | | | 0.408 | | No | 6 (50.0) | 4 (33.3) | | | Yes | 6 (50.0) | 8 (66.7) | |
| | Stroke, n (%) | | | 0.653 | | No | 8 (66.7) | 9 (75.0) | | | Yes | 4 (33.3) | 3 (25.0) | |
| | Hyperlipidaemia, n (%) | | | 0.408 | | No | 6 (50.0) | 8 (66.7) | | | Yes | 6 (50.0) | 4 (33.3) | |
| | CYP2C192, n (%) | | | 1.000 | | GG | 8 (66.7) | 8 (66.7) | | | GA | 4 (33.3) | 4 (33.3) | |
| | CYP2C193, n (%) | | | 0.855 | | GG | 5 (41.7) | 5 (41.7) | | | GA | 4 (33.3) | 5 (41.7) | | | AA | 3 (25.0) | 2 (16.7) | |
| | CYP2C193, n (%) | | | 1.000 | | GG | 5 (41.7) | 5 (41.7) | | | GA + AA | 7 (58.3) | 7 (58.3) | |
| | CYP2C1917, n (%) | | | 0.219 | | GG | 5 (41.7) | 8 (66.7) | | | GA | 7 (58.3) | 4 (33.3) | |
|
|
